0001140361-12-048772.txt : 20121127 0001140361-12-048772.hdr.sgml : 20121127 20121127124705 ACCESSION NUMBER: 0001140361-12-048772 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20121127 DATE AS OF CHANGE: 20121127 EFFECTIVENESS DATE: 20121127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CERAPEDICS INC CENTRAL INDEX KEY: 0001393439 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-181546 FILM NUMBER: 121226016 BUSINESS ADDRESS: STREET 1: 11025 DOVER STREET STREET 2: SUITE 1600 CITY: WESTMINSTER STATE: CO ZIP: 80021 BUSINESS PHONE: 303-974-6281 MAIL ADDRESS: STREET 1: 11025 DOVER STREET STREET 2: SUITE 1600 CITY: WESTMINSTER STATE: CO ZIP: 80021 D/A 1 primary_doc.xml X0706 D/A LIVE 0001393439 CERAPEDICS INC 11025 DOVER STREET SUITE 1600 WESTMINSTER CO COLORADO 80021 303-974-6281 DELAWARE None None Corporation true Paul J. Mraz c/o Cerapedics Inc. 11025 Dover Street, Suite 1600 Westminster CO COLORADO 80021 Executive Officer Director Andrew Handwerker c/o Cerapedics Inc. 11025 Dover Street, Suite 1600 Westminster CO COLORADO 80021 Executive Officer Chau Khuong c/o Orbimed Advisors 601 Lexington Street, 54th Floor New York NY NEW YORK 10022 Director Chen Schor c/o Cerapedics Inc. 11025 Dover Street, Suite 1600 Westminster CO COLORADO 80021 Director Jonathan Silverstein c/o Orbimed Advisors 601 Lexington Street, 54th Floor New York NY NEW YORK 10022 Director Andrew J. Tofe c/o Cerapedics Inc. 11025 Dover Street, Suite 1600 Westminster CO COLORADO 80021 Director Ken S. Abramowitz c/o NGN Capital 369 Lexington Avenue, 17th Floor New York NY NEW YORK 10017 Director Samuel S. Wu c/o MedImmune Ventures, Inc. One MedImmune Way Gaithersburg MD MARYLAND 20878 Director Biotechnology Decline to Disclose 06 true 0001140361-12-033515 2012-07-12 false true false 0 19090328 0 19090328 Issuer sold $16,000,000 of Series C Convertible Preferred Stock for cash and converted Promissory Notes worth $3,090,328 of combined principal and interest into Series C Convertible Preferred Stock. false 5 0 0 0 false CERAPEDICS INC /s/Paul J. Mraz Paul J. Mraz Chief Executive Officer 2012-11-26